On October 26, 2024, a major conference on “New Approach to Allergic Rhinitis and Chronic Rhinosinusitis” was held at the Radisson Hotel in Baku. The event, which aroused great interest in the medical community, brought together experts working in the fields of otolaryngology and allergology. Modern approaches, clinical research results and innovative solutions in the treatment of diseases were discussed at the conference held with the participation of local and foreign experts.
Purpose of the Event
The main objective of the conference was to introduce the Mometasone Zentiva brand to medical professionals and provide information on modern methods of treatment of allergic rhinitis and chronic nasal sinusitis. The event also aimed to promote the exchange of experience and knowledge among doctors and to disseminate scientific information on the effectiveness of new medicines.
Event leaders
Well-known leaders in the medical field of Azerbaijan participated in the organization and conduct of the conference:
Nazim Huseynov: He holds a leading position in the Azerbaijani medical community and is a professor of ENT diseases.
Akif Efendiyev: He is a well-known medical specialist with extensive experience in the treatment and diagnosis of chronic rhinosinusitis.
Lecturers: Synthesis of Practice and Science
Within the framework of the event, two key lecturers spoke:
Svistushkin Mikhail: Internationally recognized expert and researcher on allergic diseases. In his speech, detailed information on the etiology, risk factors and diagnostic methods of allergic rhinitis was presented.
Mazahir Guliyev: specialist in the treatment of chronic rhinosinusitis, having a leading position in the field of local medicine. He spoke about the effectiveness of modern anti-inflammatory drugs, especially Mometasone Zentiva.
Topics Discussed
1. Etiology and Diagnosis of Allergic Rhinitis
Causes of the disease and risk factors that increase its development (for example, genetic predisposition, environmental influences).
Application of modern diagnostic technologies, including specific tests for accurate identification of allergens.
Impact of allergic rhinitis on patient quality of life and individual approaches to manage these problems.
2. Modern Treatment of Chronic Rhinosinusitis
Use and clinical effectiveness of modern anti-inflammatory drugs, especially Mometasone Zentiva.
Application of minimally invasive methods in patient treatment.
The importance of a multidisciplinary approach to prevent complications of chronic rhinosinusitis.
Significance of the event
This conference became an important platform for the dissemination of scientific knowledge and exchange of experience for local and international experts. In particular, the clinical research results presented on the effectiveness of the drug Mometasone Zentiva and its role in patient treatment were highly appreciated by the participants of the event.
Also, the event provided an opportunity for ENT and allergist doctors to get to know modern treatment methods that they can use in daily practice.
Event Results
The main results obtained at the end of the conference:
Acquisition of new knowledge: Doctors gained detailed information about modern treatment principles and innovative approaches.
Applicability to clinical practice: The information presented and the topics discussed helped identify concrete steps that could be implemented in patient care.
New opportunities for cooperation: relations between local and international experts were established, the basis for future cooperation was created.